Crossing the quality chasm in neonatal-perinatal medicine

Clinics in Perinatology

Volumn 37, Issue 1, 2010, Pages 1-10

  Ellsbury, Dan L ^a  

^a PEDIATRIX MEDICAL GROUP   (United States)

Author keywords

Complex adaptive systems; Neonatal medicine; Quality chasm; Quality improvement

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; GENTAMICIN; HISTAMINE H2 RECEPTOR ANTAGONIST; METOCLOPRAMIDE; SURFACTANT;

BRAIN HEMORRHAGE; BREAST MILK; CATHETER CARE; CENTRAL NERVOUS SYSTEM DISEASE; CRITICAL THINKING; GASTROESOPHAGEAL REFLUX; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; INTESTINAL DYSMOTILITY; NECROTIZING ENTEROCOLITIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN APNEA; NEWBORN CARE; NEWBORN INTENSIVE CARE; OXYGEN THERAPY; PERINATAL CARE; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SEPSIS; SYSTEMIC DISEASE; THERMOREGULATION; TOTAL QUALITY MANAGEMENT; TREATMENT DURATION;

EVIDENCE-BASED MEDICINE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE, NEONATAL; NEONATOLOGY; PERINATOLOGY; QUALITY ASSURANCE, HEALTH CARE; SYSTEMS INTEGRATION;

EID: 77950961980     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clp.2010.01.001     Document Type: Review

References (83)

1. Institute of Medicine Crossing the quality chasm: a new health system for the 21st century 2001, National Academy Press, Washington, DC.
2. Daniels M., Hill A.B. Chemotherapy of pulmonary tuberculosis in young adults; an analysis of the combined results of three Medical Research Council trials. Br Med J 1952, 1(4769):1162-1168.
3. Chassin M.R., Galvin R.W. The urgent need to improve health care quality. Institute of Medicine National Roundtable on Health Care Quality. JAMA 1998, 280(11):1000-1005.
4. Chassin M.R. Is health care ready for Six Sigma quality?. Milbank Q 1998, 76(4):565-591. 510.
5. Balas E.A., Boren S.A. Managing clinical knowledge for health care improvement. Yearbook of medical informatics 2000, 65-70. National Library of Medicine, Bethesda (MD). J. Bemmel, A.T. McCray (Eds.).
6. Chedoe I., Molendijk H.A., Dittrich S.T., et al. Incidence and nature of medication errors in neonatal intensive care with strategies to improve safety: a review of the current literature. Drug Saf 2007, 30(6):503-513.
7. Takata G.S., Mason W., Taketomo C., et al. Development, testing, and findings of a pediatric-focused trigger tool to identify medication-related harm in US children's hospitals. Pediatrics 2008, 121(4):e927-e935.
8. Brennan T.A., Leape L.L., Laird N.M., et al. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med 1991, 324(6):370-376.
9. Suresh G., Horbar J.D., Plsek P., et al. Voluntary anonymous reporting of medical errors for neonatal intensive care. Pediatrics 2004, 113(6):1609-1618.
10. Snijders C., van Lingen R.A., Molendijk A., et al. Incidents and errors in neonatal intensive care: a review of the literature. Arch Dis Child Fetal Neonatal Ed 2007, 92(5):F391-F398.
11. To err is human: building a safer health system 2000, 26-48. National Academy Press, Washington, DC. L.T. Kohn, J.M. Corrigan, M.S. Donaldson (Eds.).
12. Gill A.W., Australian and New Zealand Neonatal Network Analysis of neonatal nosocomial infection rates across the Australian and New Zealand Neonatal Network. J Hosp Infect 2009, 72(2):155-162.
13. Kusuda S., Fujimura M., Sakuma I., et al. Neonatal Research Network, Japan. Morbidity and mortality of infants with very low birth weight in Japan: center variation. Pediatrics 2006, 118(4):e1130-e1138.
14. Aziz K., McMillan D.D., Andrews W., et al. Canadian Neonatal Network. Variations in rates of nosocomial infection among Canadian neonatal intensive care units may be practice-related. BMC Pediatr 2005, 5:22.
15. Powers N.G., Bloom B., Peabody J., et al. Site of care influences breastmilk feedings at NICU discharge. J Perinatol 2003, 23(1):10-13.
16. Gartner L.M., Morton J., Lawrence R.A., et al. American Academy of Pediatrics Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics 2005, 115(2):496-506.
17. NIH consensus development panel on the effect of corticosteroids for fetal maturation on perinatal outcomes. Effect of corticosteroids for fetal maturation on perinatal outcomes. JAMA 1995, 273:413-418.
18. Roberts D., Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006, (3). CD004454.
19. Howell E.A., Stone J., Kleinman L.C., et al. Approaching NIH guideline recommended care for maternal-infant health: clinical failures to use recommended antenatal corticosteroids. Matern Child Health J 2009, [Epub ahead of print]. DOI:10.1007/s10995-009-0480-3.
20. Bronstein J.M., Goldenberg R.L. Practice variation in the use of corticosteroids: a comparison of eight datasets. Am J Obstet Gynecol 1995, 173:296-298.
21. Bronstein J.M., Cliver S.P., Goldenberg R.L. Practice variation in the use of interventions in high risk obstetrics. Health Serv Res 1998, 32:825-839.
22. Wright L.L., Horbar J.D., Gunkel H., et al. Evidence from multicenter networks on the current use and effectiveness of antenatal corticosteroids in low birth weight infants. Am J Obstet Gynecol 1995, 173:263-269.
23. Wirtschafter D.D., Danielsen B.H., Main E.K., et al. California Perinatal Quality Care Collaborative. Promoting antenatal steroid use for fetal maturation: results from the California Perinatal Quality Care Collaborative. J Pediatr 2006, 148(5):606-612.
24. Halliday H.L. Surfactants: past, present and future. J Perinatol 2008, 28(Suppl 1):S47-S56.
25. Seger N., Soll R. Animal derived surfactant extract for treatment of respiratory distress syndrome. Cochrane Database Syst Rev 2009, (2). CD007836. DOI: 10.1002/14651858. CD007836.
26. Engle W.A. American Academy of Pediatrics Committee on Fetus and Newborn. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics 2008, 121(2):419-432.
27. Horbar J.D., Carpenter J.H., Buzas J., Vermont Oxford Network, et al. Timing of initial surfactant treatment for infants 23 to 29 weeks' gestation: is routine practice evidence based?. Pediatrics 2004, 113(6):1593-1602.
28. Koll B.S., Straub T.A., Jalon H.S., et al. The CLABs collaborative: a regionwide effort to improve the quality of care in hospitals. Jt Comm J Qual Patient Saf 2008, 34(12):713-723.
29. Jeffries H.E., Mason W., Brewer M., et al. Prevention of central venous catheter-associated bloodstream infections in pediatric intensive care units: a performance improvement collaborative. Infect Control Hosp Epidemiol 2009, 30(7):645-651.
30. Costello J.M., Morrow D.F., Graham D.A., et al. Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit. Pediatrics 2008, 121(5):915-923.
31. McKee C., Berkowitz I., Cosgrove S.E., et al. Reduction of catheter-associated bloodstream infections in pediatric patients: experimentation and reality. Pediatr Crit Care Med 2008, 9(1):40-46.
32. Wirtschafter D.D., Pettit J., Kurtin P., et al. A statewide quality improvement collaborative to reduce neonatal central line-associated blood stream infections. J Perinatol 2009, [Epub ahead of print]. DOI:10.1038/jp.2009.172.
33. Pronovost P. Interventions to decrease catheter-related bloodstream infections in the ICU: the Keystone Intensive Care Unit Project. Am J Infect Control 2008, 36(10):S171.e1-S171.e5.
34. Chow L.C., Wright K.W., Sola A., CSMC Oxygen Administration Study Group Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants?. Pediatrics 2003, 111(2):339-345.
35. Ellsbury D.L. Quality improvement program for the reduction of retinopathy of prematurity. E-PAS 2006, (59). [abstract], 3602.469.
36. Sears J.E., Pietz J., Sonnie C., et al. A change in oxygen supplementation can decrease the incidence of retinopathy of prematurity. Ophthalmology 2009, 116(3):513-518.
37. Deulofeut R., Critz A., Adams-Chapman I., et al. Avoiding hyperoxia in infants < or = 1250 g is associated with improved short-and long-term outcomes. J Perinatol 2006, 26(11):700-705.
38. Vanderveen D.K., Mansfield T.A., Eichenwald E.C. Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity. J AAPOS 2006, 10(5):445-448.
39. Wright K.W., Sami D., Thompson L., et al. A physiologic reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity. Trans Am Ophthalmol Soc 2006, 104:78-84.
40. Hagadorn J.I., Furey A.M., Nghiem T.H., et al. AVIOx Study Group. Achieved versus intended pulse oximeter saturation in infants born less than 28 weeks' gestation: the AVIOx study. Pediatrics 2006, 118(4):1574-1582.
41. Clucas L., Doyle L.W., Dawson J., et al. Compliance with alarm limits for pulse oximetry in very preterm infants. Pediatrics 2007, 119(6):1056-1060.
42. O'Donovan D.J., Fernandes C.J. Free radicals and diseases in premature infants. Antioxid Redox Signal 2004, 6(1):169-176.
43. Sola A., Rogido M.R., Deulofeut R. Oxygen as a neonatal health hazard: call for détente in clinical practice. Acta Paediatr 2007, 96(6):801-812.
44. Silvermam W.A., Fertig J.W., Berger A.P. The influence of the thermal environment upon the survival of newly born premature infants. Pediatrics 1958, 22(5):876-886.
45. McCall E.M., Alderdice F.A., Halliday H.L., et al. Interventions to prevent hypothermia at birth in preterm and/or low birthweight infants. Cochrane Database Syst Rev 2008, (1). CD004210.
46. Laptook A.R., Watkinson M. Temperature management in the delivery room. Semin Fetal Neonatal Med 2008, 13(6):383-391.
47. Laptook A.R., Salhab W., Bhaskar B., Neonatal Research Network Admission temperature of low birth weight infants: predictors and associated morbidities. Pediatrics 2007, 119(3):e643-e649.
48. Knobel R.B., Vohra S., Lehmann C.U. Heat loss prevention in the delivery room for preterm infants: a national survey of newborn intensive care units. J Perinatol 2005, 25(8):514-518.
49. Cramer K., Wiebe N., Hartling L., et al. Heat loss prevention: asystematic review of occlusive skin wrap for premature neonates. J Perinatol 2005, 25(12):763-769.
50. Spitzer A.R., Kirkby S., Kornhauser M. Practice variation in suspected neonatal sepsis: a costly problem in neonatal intensive care. J Perinatol 2005, 25(4):265-269.
51. Cotten C.M., Taylor S., Stoll B., et al. NICHD Neonatal Research Network. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009, 123(1):58-66.
52. Cordero L., Ayers L.W. Duration of empiric antibiotics for suspected early-onset sepsis in extremely low birth weight infants. Infect Control Hosp Epidemiol 2003, 24(9):662-666.
53. Bizzarro M.J., Gallagher P.G. Antibiotic-resistant organisms in the neonatal intensive care unit. Semin Perinatol 2007, 31(1):26-32.
54. Hibbs A.M., Lorch S.A. Metoclopramide for the treatment of gastroesophageal reflux disease in infants: a systematic review. Pediatrics 2006, 118(2):746-752.
55. Wheatley E., Kennedy K.A. Cross-over trial of treatment for bradycardia attributed to gastroesophageal reflux in preterm infants. J Pediatr 2009, 155(4):516-521.
56. Clark R.H., Spitzer A.R. Patience is a virtue in the management of gastroesophageal reflux. J Pediatr 2009, 155(4):464-465.
57. Paturi B., Ryan R.M., Michienzi K.A., et al. Galactorrhea with metoclopramide use in the neonatal unit. J Perinatol 2009, 29(5):391-392.
58. Malcolm W.F., Gantz M., Martin R.J., et al. National Institute of Child Health and Human Development Neonatal Research Network. Use of medications for gastroesophageal reflux at discharge among extremely low birth weight infants. Pediatrics 2008, 121(1):22-27.
59. Mejia N.I., Jankovic J. Metoclopramide-induced tardive dyskinesia in an infant. Mov Disord 2005, 20(1):86-89.
60. Finer N.N., Higgins R., Kattwinkel J., et al. Summary proceedings from the apnea-of-prematurity group. Pediatrics 2006, 117(3 Pt 2):S47-S51.
61. Di Fiore J.M., Arko M., Whitehouse M., et al. Apnea is not prolonged by acid gastroesophageal reflux in preterm infants. Pediatrics 2005, 116(5):1059-1063.
62. Poets C.F. Gastroesophageal reflux: a critical review of its role in preterm infants. Pediatrics 2004, 113(2):e128-e132.
63. Peter C.S., Sprodowski N., Bohnhorst B., et al. Gastroesophageal reflux and apnea of prematurity: no temporal relationship. Pediatrics 2002, 109(1):8-11.
64. Kenney C., Hunter C., Davidson A., et al. Metoclopramide, an increasingly recognized cause of tardive dyskinesia. J Clin Pharmacol 2008, 48(3):379-384.
65. Clark R.H., Bloom B.T., Spitzer A.R., et al. Reported medication use in the neonatal intensive care unit: data from a large national data set. Pediatrics 2006, 117(6):1979-1987.
66. Guillet R., Stoll B.J., Cotten C.M., et al. National Institute of Child Health and Human Development Neonatal Research Network. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2006, 117(2):e137-e142.
67. Clark R.H., Bloom B.T., Spitzer A.R., et al. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics 2006, 117(1):67-74.
68. Cotten C.M., McDonald S., Stoll B., et al. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics 2006, 118(2):717-722.
69. Benjamin D.K., DeLong E.R., Steinbach W.J., et al. Empirical therapy for neonatal candidemia in very low birth weight infants. Pediatrics 2003, 112(3 Pt 1):543-547.
70. Benjamin D.K., Stoll B.J., Fanaroff A.A., et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006, 117(1):84-92.
71. Zaoutis T.E., Goyal M., Chu J.H., et al. Risk factors for and outcomes of bloodstream infection caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species in children. Pediatrics 2005, 115(4):942-949.
72. Linkin D.R., Fishman N.O., Patel J.B., et al. Risk factors for extended-spectrum beta-lactamase-producing Enterobacteriaceae in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2004, 25(9):781-783.
73. Berwick D.M. A primer on leading the improvement of systems. BMJ 1996, 312(7031):619-622.
74. Deming W.E. Out of the crisis 1986, Massachusetts Institute of Technology, Cambridge (MA).
75. Deming W.E. The new economics for industry, government, education 2000, Massachusetts Institute of Technology, Cambridge (MA). 2nd edition.
76. Plsek P. Redesigning healthcare with insights from the science of complex adaptive systems. Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century 2001, National Academy Press, Washington, DC, 309-22.
77. Plsek P.E., Greenhalgh T. Complexity science: the challenge of complexity in health care. BMJ 2001, 323(7313):625-628.
78. Plsek P.E., Wilson T. Complexity, leadership, and management in healthcare organisations. BMJ 2001, 323(7315):746-749.
79. Wilson T., Holt T., Greenhalgh T. Complexity science: complexity and clinical care. BMJ 2001, 323(7314):685-688.
80. Fraser S.W., Greenhalgh T. Coping with complexity: educating for capability. BMJ 2001, 323(7316):799-803.
81. Stacey R.D. Complexity and creativity in organizations 1996, Berrett-Koehler, San Francisco (CA).
82. Nelson E.C., Batalden P.B., Godfrey M.M. Quality by design: a clinical microsystems approach 2007, Jossey-Bass, San Francisco (CA).
83. Goethe J.W., Saunders T.B. The maxims and reflections of Goethe 1906, MacMillan, New York (NY), p. 144.